FDA Inspection 984072 — Andrew Waxler, M.D.
The FDA completed an inspection of Andrew Waxler, M.D. on August 5, 2016 in Wyomissing, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 5, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wyomissing, PA (United States)
Additional Details
Clinical Investigator (CI)